Physician

Abdul Karim Garuba, MD

According to 2025 Medicare claims, Abdul Garuba, MD (NPI: 1063483113) practices internal medicine in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is POLYCLINIC MEDICAL CENTER, INC. (NPI: 1821059650; TIN: 010619599) and primary practice location at 28105-9704. Garuba is affiliated with the Aledade A4548 NC Legacy MSSP Enhanced (ACO ID: A4548), participating under the MSSP model.

Garuba's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 66 traditional Medicare patients, billed 588 HCPCS/CPT codes, and received $32,753 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 2,111 prescription claims across 179 beneficiaries totaling $243,785 in drug costs, led by Toujeo Max Solostar (Insulin Glargine,hum.Rec.Anlog). 2022 DME data shows 19 claims. Open Payments data shows 28 records totaling $507. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $125,512 to $32,753. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $4,384 to $649.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	224	2,226	$125,512
2016	235	2,150	$105,627
2017	220	2,115	$95,899
2018	193	1,988	$84,782
2019	160	1,851	$81,706
2020	139	1,394	$62,337
2021	111	1,152	$68,157
2022	83	1,652	$53,268
2023	82	897	$43,523
2024	66	588	$32,753

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	286	4,591	$331,043
2016	281	4,272	$292,047
2017	276	4,107	$267,044
2018	274	3,560	$255,208
2019	236	3,646	$341,202
2020	229	3,580	$393,892
2021	222	3,599	$465,661
2022	213	2,876	$381,026
2023	187	2,084	$254,579
2024	179	2,111	$243,785

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	42	142	$2,642
2016	29	73	$1,267
2017	33	72	$892
2018	29	71	$683
2019	30	115	$2,486
2020	17	102	$2,093
2021	11	45	$590
2022	N/R	19	$447
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	43	43	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	49	111	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	48	169	$54
G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	29	29	$24
G0444	Annual depression screening, 5 to 15 minutes	41	41	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	41	2,093	$55,494
Rybelsus	Semaglutide	12	1,080	$33,618
Eliquis	Apixaban	20	1,320	$24,173
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	804	$20,346
Mounjaro	Tirzepatide	11	312	$11,295

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$507	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdul Karim Garuba, MD?

Tedicare shows public-source Medicare data for Abdul Karim Garuba, MD (NPI 1063483113), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Karim Garuba, MD have ACO affiliation data?

Abdul Karim Garuba, MD is shown with ACO affiliation data for Aledade A4548 NC Legacy MSSP Enhanced (MSSP, ACO ID A4548).

What billing organization is linked to Abdul Karim Garuba, MD?

Abdul Karim Garuba, MD is linked to POLYCLINIC MEDICAL CENTER, INC. (billing NPI 1821059650) in the available physician profile data.

Does Abdul Karim Garuba, MD have Open Payments data?

Abdul Karim Garuba, MD has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.